Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionComerica Bank
Latest Disclosed Ownership136 shares
Latest Disclosed Value $ 477
Comerica Bank reports 89.99% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 136 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $375 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 1,358 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -89.99% during the quarter. The current value of the position is $332 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 136 -1,222 -89.99 0 -100.00 0.0000
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,358 1,070 371.53 4 0.0000
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 288 -815,701 -99.96 1 -100.00 0.0000
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 815,989 35,609 4.56 5,443 -44.52 0.0229
2025-02-14 2024-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 780,380 -5,146 -0.66 9,809 -32.39 0.0396
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 780,380 -5,146 9,809 0.0329
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 785,526 98,872 14.40 14,509 -1.86 0.0574
2024-08-15 2024-06-30 13F ROCKET PHARMACEUTICALS COMMON 77313F106 686,654 152,129 28.46 14,784 2.66 0.0615
2024-05-16 2024-03-31 13F ROCKET PHARMACEUTICALS COMMON 77313F106 534,525 -23,500 -4.21 14,400 -13.90 0.0621
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COMMON 77313F106 558,025 117,949 26.80 16,724 85.47 0.0770
2023-11-21 2023-09-30 13F ROCKET PHARMACEUTICALS COMMON 77313F106 440,076 440,076 9,017 0.0470
2023-08-22 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -288,316 -100.00 0 -100.00
2023-01-26 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 288,316 39,806 16.02 6 -99.85 0.0494
2022-10-28 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 248,510 50 0.02 4,068 -1.95 0.0343
2022-08-02 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 248,460 116,503 88.29 4,149 129.86 0.0341
2022-04-27 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 131,957 2,940 2.28 1,805 -14.66 0.0131
2022-02-18 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 129,017 12,787 11.00 2,115 -38.09 0.0156
2021-11-22 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 116,230 -3,962 -3.30 3,416 3.64 0.0206
2021-08-26 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 120,192 39,487 48.93 3,296 -8.82 0.0197
2021-04-28 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 80,705 24,894 44.60 3,615 17.75 0.0216
2021-01-28 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 55,811 26,665 91.49 3,070 274.85 0.0195
2020-10-30 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 29,146 3,280 12.68 819 25.04 0.0059
2020-07-31 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 25,866 -5,285 -16.97 655 21.07 0.0050
2020-05-01 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 31,151 4,086 15.10 541 -9.23 0.0050
2020-02-07 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 27,065 -1,090 -3.87 596 64.19 0.0045
2019-10-31 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 28,155 7,329 35.19 363 38.02 0.0029
2019-08-02 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 20,826 20,826 263 0.0021
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.